Mark Cuban says Trump's new drug platform could succeed if it forces pharma managers to change: 'If that happens, Trump gets all the credit' | Fortune

Cuban’s Cost Plus Drugs, which he founded in 2022, similarly provides direct-to-consumer discounted pharmaceuticals.

Raccontata dafortune.com